Role of tumor‑associated neutrophils in lung cancer (Review)
- Authors:
- Jinhua Zhou
- Huan Liu
- Shulong Jiang
- Wei Wang
-
Affiliations: Department of Respiratory Medicine, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Department of Emergency Internal Medicine, Jining First People's Hospital, Jining, Shandong 272000, P.R. China, Clinical Medical Laboratory Center, Jining First People's Hospital, Jinning, Shandong 272000, P.R. China - Published online on: November 8, 2022 https://doi.org/10.3892/ol.2022.13588
- Article Number: 2
-
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].
This article is mentioned in:
Abstract
 |
 |
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Rosen R and Karachaliou N: Large-scale screening for somatic mutations in lung cancer. Lancet. 387:1354–1356. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu L, Wang X, Ji Z, Wang J, Bi N, Hui Z, Lyu J, Liang J, Zhou Z, Feng Q, et al: Outcome of concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer patients. Zhonghua Zhong Liu Za Zhi. 37:863–867. 2015.(In Chinese). PubMed/NCBI | |
|
Moro-Sibilot D, Smit E, de Castro Carpeño J, Lesniewski-Kmak K, Aerts J, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, et al: Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study. Lung Cancer. 88:215–222. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lu H and Jiang Z: Advances in antibody therapeutics targeting small-cell lung cancer. Adv Clin Exp Med. 27:1317–1323. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bielenberg DR and Zetter BR: The contribution of angiogenesis to the process of metastasis. Cancer J. 21:267–273. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Nemeth JA, Cher ML, Zhou Z, Mullins C, Bhagat S and Trikha M: Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases. Clin Exp Metastasis. 20:413–420. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y and Cao X: Characteristics and significance of the pre-metastatic niche. Cancer Cell. 30:668–681. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Quail DF and Joyce JA: Microenvironmental regulation of tumor progression and metastasis. Nat Med. 19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sceneay J, Smyth MJ and Möller A: The pre-metastatic niche: Finding common ground. Cancer Metastasis Rev. 32:449–464. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shoenfeld Y, Tal A, Berliner S and Pinkhas J: Leukocytosis in non hematological malignancies-a possible tumor-associated marker. J Cancer Res Clin Oncol. 111:54–58. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Tecchio C, Scapini P, Pizzolo G and Cassatella MA: On the cytokines produced by human neutrophils in tumors. Semin Cancer Biol. 23:159–170. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Houghton AM: The paradox of tumor-associated neutrophils. Cell Cycle. 9:1732–1737. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gregory A and Houghton AM: Tumor-associated neutrophils: New targets for cancer therapy. Cancer Research. 71:2411–2416. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kim J and Bae JS: Tumor-Associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016:60581472016. View Article : Google Scholar : PubMed/NCBI | |
|
Borregaard N: Neutrophils, from marrow to microbes. Immunity. 33:657–670. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Cortez-Retamozo V, Etzrodt M, Newton A, Rauch PJ, Chudnovskiy A, Berger C, Ryan RJ, Iwamoto Y, Marinelli B, Gorbatov R, et al: Origins of tumor associated macrophages and neutrophils. Proc Natl Acad Sci USA. 109:2491–2496. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Stöth M, Freire Valls A, Chen M, Hidding S, Knipper K, Shen Y, Klose J, Ulrich A, Ruiz de Almodovar C, Schneider M and Schmidt T: Splenectomy reduces lung metastases and tumoral and metastatic niche inflammation. Int J Cancer. 145:2509–2520. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, Stephen TL, Ranganathan A, Deshpande C, Akimova T, Vachani A, Litzky L, Hancock WW, et al: Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest. 124:5466–5480. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Piccard H, Muschel RJ and Opdenakker G: On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol. 82:296–309. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sionov RV, Fridlender ZG and Granot Z: The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 8:125–158. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Coffelt SB, Wellenstein MD and de Visser KE: Neutrophils in cancer: Neutral no more. Nat Rev Cancer. 16:443–446. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Houghton AM: The paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances. Cell Cycle. 9:1732–1737. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Shen M, Hu P, Donskov F, Wang G, Liu Q and Du J: Tumorassociated neutrophils as a new prognostic factor in cancer: A systematic review and meta-analysis. PLoS One. 9:e982592014. View Article : Google Scholar : PubMed/NCBI | |
|
Uribe-Querol E and Rosales C: Neutrophils in cancer: Two sides of the same coin. J Immunol Res. 2015:9836982015. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Wu S, Yang Y, Zhao M, Zhu G and Hou Z: The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer. Biomed Pharmacother. 95:55–61. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Shaul ME, Eyal O, Guglietta S, Aloni P, Zlotnik A, Forkosh E, Levy L, Weber LM, Levin Y, Pomerantz A, et al: Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis. FASEB J. 34:4204–4218. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Chen H, Mao B, Zhou Y, Shi X, Tang L, Jiang H, Wang G and Zhuang W: Transcriptional characterization of the tumor immune microenvironment and its prognostic value for locally advanced lung adenocarcinoma in a Chinese population. Cancer Manag Res. 11:9165–9173. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Sebastian NT, Raj R, Prasad R, Barney C, Brownstein J, Grecula J, Haglund K, Xu-Welliver M, Williams TM and Bazan JG: Association of Pre- and Posttreatment neutrophil-lymphocyte ratio with recurrence and mortality in locally advanced non-small cell lung cancer. Front Oncol. 10:5988732020. View Article : Google Scholar : PubMed/NCBI | |
|
Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W, Templeton AJ and Früh M: Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 111:176–181. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao K, Wang C, Shi F, Huang Y, Ma L, Li M and Song Y: Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy. BMC Cancer. 21:662021. View Article : Google Scholar : PubMed/NCBI | |
|
Ilie M, Hofman V, Ortholan C, Bonnetaud C, Coëlle C, Mouroux J and Hofman P: Predictive clinical outcome of the intratumoralCD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer. 118:1726–1737. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Fridlender ZG and Albelda SM: Tumor-associated neutrophils: Friend or foe? Carcinogenesis. 33:949–955. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Dumitru CA, Lang S and Brandau S: Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression. Semin Cancer Biol. 23:141–148. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Abe H, Morikawa T, Saito R, Yamashita H, Seto Y and Fukayama M: In Epstein-Barr virus-associated gastric carcinoma a high density ofCD66b-positive tumor-associated neutrophils is associated with intestinal-type histology and low frequency of lymph node metastasis. Virchows Arch. 468:539–548. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
López-Lago MA, Posner S, Thodima VJ, Molina AM, Motzer RJ and Chaganti RS: Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene. 32:1752–1760. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Houghton AM, Rzymkiewicz DM, Ji H, Gregory AD, Egea EE, Metz HE, Stolz DB, Land SR, Marconcini LA, Kliment CR, et al: Neutrophil Elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med. 16:219–223. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Deryugina EI, Zajac E, Juncker-Jensen A, Kupriyanova TA, Welter L and Quigley JP: Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment. Neoplasia. 16:771–788. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Deryugina EI and Quigley JP: Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol. 44–46. 94–112. 2015.PubMed/NCBI | |
|
Grunwald B, Vandooren J, Locatelli E, Fiten P, Opdenakker G, Proost P, Krüger A, Lellouche JP, Israel LL, Shenkman L and Comes Franchini M: Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer. J Control Release. 239:39–48. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Andzinski L, Kasnitz N, Stahnke S, Wu CF, Gereke M, von Köckritz-Blickwede M, Schilling B, Brandau S, Weiss S and Jablonska J: Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int J Cancer. 138:1982–1993. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang N, Wang Q, Chi J, Xiang F, Lin M, Wang W, Wei F and Feng Y: Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma. Cancer Sci. 110:519–529. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Krstic J and Santibanez JF: Transforming growth factor-beta and matrix metalloproteinases: Functional interactions in tumor Stroma-infiltrating myeloid cells. ScientificWorldJournal. 2014:5217542014. View Article : Google Scholar : PubMed/NCBI | |
|
Kim Y, Lee D, Lee J, Lee S and Lawler S: Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model. PLoS One. 14:e02110412019. View Article : Google Scholar : PubMed/NCBI | |
|
Shaul ME, Levy L, Sun J, Mishalian I, Singhal S, Kapoor V, Horng W, Fridlender G, Albelda SM and Fridlender ZG: Tumor-associated neutrophils display a distinct N1 profile following TGF-β modulation: A transcriptomics analysis of pro-vs. Antitumor TANs. Oncoimmunology. 5:e12322212016. View Article : Google Scholar : PubMed/NCBI | |
|
Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS and Albelda SM: Polarization of tumor-associated neutrophil phenotype by TGF-beta: ‘N1’ versus ‘N2’ TAN. Cancer Cell. 16:183–194. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Saha S and Biswas SK: Tumor-Associated neutrophils show phenotypic and functional divergence in human lung cancer. Cancer Cell. 30:11–13. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Qiao X, Shi H, Han X, Liu W, Tian X and Zeng X: Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation. Tumour Biol. 37:5397–5404. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mishalian I, Bayuh R, Levy L, Zolotarov L, Michaeli J and Fridlender ZG: Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol Immunother. 62:1745–1756. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
McDonald B, Urrutia R, Yipp BG, Jenne CN and Kubes P: Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe. 12:324–333. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, Brinkmann V, Jungblut PR and Zychlinsky A: Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 5:e10006392009. View Article : Google Scholar : PubMed/NCBI | |
|
Spicer JD, McDonald B, Cools-Lartigue JJ, Chow SC, Giannias B, Kubes P and Ferri LE: Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells. Cancer Res. 72:3919–3927. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rayes RF, Mouhanna JG, Nicolau I, Bourdeau F, Giannias B, Rousseau S, Quail D, Walsh L, Sangwan V, Bertos N, et al: Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects. JCI Insight. 5:e1280082019. View Article : Google Scholar : PubMed/NCBI | |
|
Erpenbeck L and Schön MP: Neutrophil extracellular traps: Protagonists of cancer progression? Oncogene. 36:2483–2490. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Richardson JJR, Hendrickse C, Gao-Smith F and Thickett DR: Neutrophil extracellular trap production in patients with colorectal cancer in vitro. Int J Inflam. 2017:49150622017.PubMed/NCBI | |
|
Jin W, Xu HX, Zhang SR, Li H, Wang WQ, Gao HL, Wu CT, Xu JZ, Qi ZH, Li S, et al: Tumor-Infiltrating nets predict postsurgical survival in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol. 26:635–643. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Thålin C, Lundström S, Seignez C, Daleskog M, Lundström A, Henriksson P, Helleday T, Phillipson M, Wallén H and Demers M: Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer. PLoS One. 13:e01912312018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Yang Y, Gan T, Li Y, Hu F, Hao N, Yuan B, Chen Y and Zhang M: lung cancer cells release high mobility group box 1 and promote the formation of neutrophil extracellular traps. Oncol Lett. 18:181–188. 2019.PubMed/NCBI | |
|
Najmeh S, Cools-Lartigue J, Giannias B, Spicer J and Ferri LE: Simplified human neutrophil extracellular traps (NETs) isolation and handling. J Vis Exp. 526872015.doi: 10.3791/52687. PubMed/NCBI | |
|
Cools-Lartigue J, Spicer J, McDonald B, Gowing S, Chow S, Giannias B, Bourdeau F, Kubes P and Ferri L: Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest. 123:3446–3458. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Monti M, De Rosa V, Iommelli F, Carriero MV, Terlizzi C, Camerlingo R, Belli S, Fonti R, Di Minno G and Del Vecchio S: Neutrophil extracellular traps as an adhesion substrate for difffferent tumor cells expressing RGD-binding integrins. Int J Mol Sci. 19:23502018. View Article : Google Scholar : PubMed/NCBI | |
|
Kanamaru R, Ohzawa H, Miyato H, Yamaguchi H, Hosoya Y, Lefor AK, Sata N and Kitayama J: Neutrophil extracellular traps generated by low density neutrophils obtained from peritoneal lavage fluid mediate tumor cell growth and attachment. J Vis Exp. 138:582012018.PubMed/NCBI | |
|
Yang L, Liu L, Zhang R, Hong J, Wang Y, Wang J, Zuo J, Zhang J, Chen J and Hao H: IL-8 mediates a positive loop connecting increased neutrophil extracellular traps (Nets) and colorectal cancer liver metastasis. J Cancer. 11:4384–4396. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang LY, Luo Q, Lu L, Zhu WW, Sun HT, Wei R, Lin ZF, Wang XY, Wang CQ, Lu M, et al: Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response. J Hematol Oncol. 13:32020. View Article : Google Scholar : PubMed/NCBI | |
|
Kern MA, Haugg AM, Koch AF, Schilling T, Breuhahn K, Walczak H, Fleischer B, Trautwein C, Michalski C, Schulze-Bergkamen H, et al: yclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res. 66:7059–7066. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Leng J, Han C, Demetris AJ, Michalopoulos GK and Wu T: Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: Evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology. 38:756–768. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Xu L, Stevens J, Hilton MB, Seaman S, Conrads TP, Veenstra TD, Logsdon D, Morris H, Swing DA, Patel NL, et al: COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci Transl Med. 6:242ra842014. View Article : Google Scholar : PubMed/NCBI | |
|
Takesue S, Ohuchida K, Shinkawa T, Otsubo Y, Matsumoto S, Sagara A, Yonenaga A, Ando Y, Kibe S, Nakayama H, et al: Neutrophil extracellular traps promote liver micrometastasis in pancreatic ductal adenocarcinoma via the activation of cancer-associated fibroblasts. Int J Oncol. 56:596–605. 2020.PubMed/NCBI | |
|
Xiao Y, Cong M, Li J, He D, Wu Q, Tian P, Wang Y, Yang S, Liang C, Liang Y, et al: Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation. Cancer Cell. 39:423–437.e7. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan M, Zhu H, Xu J, Zheng Y, Cao X and Liu Q: Tumor-Derived CXCL1 promotes lung cancer growth via recruitment of tumor-associated neutrophils. J Immunol Res. 2016:65304102016. View Article : Google Scholar : PubMed/NCBI | |
|
Eash KJ, Greenbaum AM, Gopalan PK and Link DC: CXCR2 and CXCR4 antagonistically regulate neutrophil traffificking from murine bone marrow. J Clin Investig. 120:2423–2431. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Raccosta L, Fontana R, Maggioni D, Lanterna C, Villablanca EJ, Paniccia A, Musumeci A, Chiricozzi E, Trincavelli ML, Daniele S, et al: The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. J Exp Med. 210:1711–1728. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Forsthuber A, Lipp K, Andersen L, Ebersberger S, Graña-Castro, Ellmeier W, Petzelbauer P, Lichtenberger BM and Loewe R: CXCL5 as regulator of neutrophil function in cutaneous melanoma. J Invest Dermatol. 139:186–194. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Viola A, Sarukhan A, Bronte V and Molon B: The pros and cons of chemokines in tumor immunology. Trends Immunol. 33:496–504. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Huang SY, Mills L, Mian B, Tellez C, McCarty M, Yang XD, Gudas JM and Bar-Eli M: Fully humanized neutralizing antibodies to interleukin-8 (ABX–IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol. 161:125–134. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Luca M, Huang S, Gershenwald JE, Singh RK, Reich R and Bar-Eli M: Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol. 151:1105–1113. 1997.PubMed/NCBI | |
|
Pignatti P, Moscato G, Casarini S, Delmastro M, Poppa M, Brunetti G, Pisati P and Balbi B: Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways. J Allergy Clin Immunol. 115:88–94. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Fortunati E, Kazemier KM, Grutters JC, Koenderman L and Van den Bosch VJ: Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin Exp Immunol. 155:559–566. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tazzyman S, Niaz H and Murdoch C: Neutrophil-mediated tumour angiogenesis: Subversion of immune responses to promote tumour growth. Semin Cancer Biol. 23:149–158. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C, Cosmi L, Lunardi C, Annunziato F, Romagnani S and Cassatella MA: Evidence for a cross-talk between human neutrophils and Th17 cells. Blood. 115:335–343. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Jungnickel C, Schmidt LH, Bittigkoffer L, Wolf L, Wolf A, Ritzmann F, Kamyschnikow A, Herr C, Menger MD, Spieker T, et al: IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth. Oncogene. 36:4182–4190. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Shojaei F, Singh M, Thompson JD and Ferrara N: Role of Bv8 in neutrophildependent angiogenesis in a transgenic model of cancer progression. Proc Natl Acad Sci. 105:2640–2645. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tazawa H, Okada F, Kobayashi T, Tada M, Mori Y, Une Y, Sendo F, Kobayashi M and Hosokawa M: Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: Implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol. 163:2221–2232. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Vannitamby A, Seow HJ, Anderson G, Vlahos R, Thompson M, Steinfort D, Irving LB and Bozinovski S: Tumour-associated neutrophils and loss of epithelial PTEN can promote corticosteroid-insensitive MMP-9 expression in the chronically inflamed lung microenvironment. Thorax. 72:1140–1143. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Coussens LM, Tinkle CL, Hanahan D and Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 103:481–490. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Shojaei F, Wu X, Zhong C, Yu L, Liang XH, Yao J, Blanchard D, Bais C, Peale FV, van Bruggen N, et al: Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature. 450:825–831. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Qu X, Zhuang G, Yu L, Meng G and Ferrara N: Induction of Bv8 expression by granulocyte colony-stimulating factor in CD11b+Gr1+ cells: Key role of Stat3 signaling. J Biol Chem. 287:19574–19584. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kowanetz M, Wu X, Lee J, Tan M, Hagenbeek T, Qu X, Yu L, Ross J, Korsisaari N, Cao T, et al: Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci USA. 107:21248–21255. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Xu J, Lamouille S and Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Hu P, Shen M, Zhang P, Zheng C, Pang Z, Zhu L and Du J: Intratumoral neutrophil granulocytes contribute to epithelial-mesenchymal transition in lung adenocarcinoma cells. Tumor Boil. 36:7789–7796. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tsai YM, Wu KL, Liu YW, Chang AW, Huang YC, Chang CY, Tsai PH, Liao SH, Hung JY and Hsu YL: Cooperation between cancer and fibroblasts in vascular mimicry and N2-type neutrophil recruitment via Notch2-Jagged1 interaction in lung cancer. Front Oncol. 11:6969312021. View Article : Google Scholar : PubMed/NCBI | |
|
Patel S, Fu S, Mastio J, Dominguez GA, Purohit A, Kossenkov A, Lin C, Alicea-Torres K, Sehgal M, Nefedova Y, et al: Unique pattern of neutrophil migration and function during tumor progression. Nat Immunol. 19:1236–1247. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Shao B, Zhao X, Liu T, Zhang Y, Sun R, Dong X, Liu F, Zhao N, Zhang D, Wu L, et al: LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma. J Cell Mol Med. 23:1363–1374. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Mayer C, Darb-Esfahani S, Meyer AS, Hübner K, Rom J, Sohn C, Braicu I, Sehouli J, Hänsch GM and Gaida MM: Neutrophil granulocytes in ovarian cancer-induction of epithelial-to-mesenchymal-transition and tumor cell migration. J Cancer. 7:546–554. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Michaeli J, Shaul ME, Mishalian I, Hovav AH, Levy L, Zolotriov L, Granot Z and Fridlender ZG: Tumor-associated neutrophils induce apoptosis of non-activated CD8 T-cells in a TNFα and NO-dependent mechanism, promoting a tumor-supportive environment. Oncoimmunology. 6:e13569652017. View Article : Google Scholar : PubMed/NCBI | |
|
Singhal S, Bhojnagarwala PS, O'Brien S, Moon EK, Garfall AL, Rao AS, Quatromoni JG, Stephen TL, Litzky L, Deshpande C, et al: Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell. 30:120–135. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Shaul ME and Fridlender ZG: Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol. 16:601–620. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Sica A, Porta C, Morlacchi S, Banfi S, Strauss L, Rimoldi M, Totaro MG and Riboldi E: Origin and functions of tumor-associated myeloid cells (TAMCs). Cancer Microenviron. 5:133–149. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lee WL and Downey GP: Leukocyte elastase: Physiological functions and role in acute lung injury. Am J Respir Crit Care Med. 164:896–904. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Wislez M, Antoine M, Rabbe N, Gounant V, Poulot V, Lavolé A, Fleury-Feith J and Cadranel J: Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchiolo alveolar carcinoma features. Clin Cancer Res. 13:3518–3527. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Gong L, Cumpian AM, Caetano MS, Ochoa CE, De la Garza MM, Lapid DJ, Mirabolfathinejad SG, Dickey BF, Zhou Q and Moghaddam SJ: Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase. Mol Cancer. 12:1542013. View Article : Google Scholar : PubMed/NCBI | |
|
Liang W, Li Q and Ferrara N: Metastatic growth instructed by neutrophil-derived transferrin. Proc Natl Acad Sci USA. 115:11060–11065. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
O'Brien S, Thomas RM, Wertheim GB, Zhang F, Shen H and Wells AD: Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production. J Immunol. 11:5118–5129. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Erbe AK, Hank JA, Morris ZS and Sondel PM: NK cell-mediated antibody dependent cellular cytotoxicity in cancer immunotherapy. Front Immunol. 6:3682015. View Article : Google Scholar : PubMed/NCBI | |
|
Amarante-Mendes GP and Gfiffith TS: Therapeutic applications of TRAIL receptor agonists in cancer and beyond. Pharmacol Ther. 155:117–131. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Granot Z, Henke E, Comen EA, King TA, Norton L and Benezra R: Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell. 20:300–314. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Jablonska S, Leschner K and Westphal S: Neutrophils responsive to endogenous IFN-β regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest. 120:1151–1164. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wu CF, Andzinski L, Kasnitz N, Kröger A, Klawonn F, Lienenklaus S, Weiss S and Jablonska J: The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung. Int J Cancer. 137:837–847. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Andzinski L, Wu CF, Lienenklaus S, Kröger A, Weiss S and Jablonska J: Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN-β. Int J Cancer. 136:572–583. 2015.PubMed/NCBI | |
|
Jablonska J, Wu CF, Andzinski L, Leschner S and Weiss S: CXCR2-mediated tumor associated neutrophil recruitment is regulated by IFN-beta. Int J Cancer. 134:1346–1358. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Carus A, Ladekarl M, Hager H, Pilegaard H, Nielsen PS and Donskov F: Tumor-associated neutrophils and macrophages in non-small cell lung cancer: No immediate impact on patient outcome. Lung Cancer. 81:130–137. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tanizaki J, Haratani K, Hayashi H, Chiba Y, Nakamura Y, Yonesaka K, Kudo K, Kaneda H, Hasegawa Y, Tanaka K, et al: Peripheral blood biomarkers associated with clinical outcome in non-small cell lung cancer patients treated with nivolumab. J Thorac Oncol. 13:97–105. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Taniguchi Y, Tamiya A, Isa SI, Nakahama K, Okishio K, Shiroyama T, Suzuki H, Inoue T, Tamiya M, Hirashima T, et al: Predictive factors for poor progression-free survival in patients with non-small cell lung cancer treated with nivolumab. Anticancer Res. 37:857–5862. 2017. | |
|
Rakaee M, Busund LT, Paulsen EE, Richardsen E, Al-Saad S, Andersen S, Donnem T, Bremnes RM and Kilvaer TK: Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer. Oncotarget. 7:72184–72196. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kubo S, Kobayashi N, Somekawa K, Hirata M, Kamimaki C, Aiko H, Katakura S, Teranishi S, Watanabe K, Hara YU, et al: Identification of biomarkers for non-small-cell lung cancer patients treated with an immune checkpoint inhibitor. Anticancer Res. 40:3889–3896. 2020. View Article : Google Scholar : PubMed/NCBI |
